Salesforce (CRM) Stock Surges After Strong Q4 Earnings and Claudeforce Integration

Key Takeaways

Table of Contents

CRM delivered adjusted earnings per share of $5.90, significantly exceeding Wall Street’s $3.27 projection, while revenue grew 10.8% to reach $11.35 billion
A strengthened collaboration with Anthropic resulted in Claude’s integration into Agentforce and the debut of “Claudeforce”
Combined annual recurring revenue for Agentforce and Data Cloud neared $3.9 billion, with Agentforce independently generating approximately $1.5 billion in ARR
The company increased its fiscal year 2027 revenue forecast to a range of $46.1 billion to $46.4 billion
Wolfe Research elevated CRM to a “strong buy” rating while Truist Securities lifted its price objective to $300

Salesforce (CRM) kicked off Monday’s trading session at $256.60, hovering close to its 52-week peak of $269.11. The upward momentum follows an impressive quarterly performance and an enhanced strategic collaboration with Anthropic that has captured investor enthusiasm.

Salesforce, Inc., CRM

For the fiscal quarter that concluded on August 26th, the enterprise software giant posted adjusted earnings per share of $5.90, substantially surpassing analyst expectations of $3.27. Total revenue reached $11.35 billion, representing a 10.8% year-over-year increase and marginally exceeding the consensus estimate of $11.33 billion.

However, there’s an important nuance to consider. Approximately $2.53 of that $5.90 earnings figure originated from strategic investment gains, with an estimated $2.7 billion in unrealized gains attributed to the company’s equity position in Anthropic. While financially significant, these gains differ fundamentally from core operational earnings.

The deepening relationship with Anthropic represents another major development. Salesforce has strengthened its collaboration with the artificial intelligence firm, seamlessly incorporating Claude technology into Agentforce while simultaneously unveiling “Claudeforce,” which integrates Salesforce CRM functionality directly within Claude’s interface. Market participants responded positively to these announcements.

The combined annual recurring revenue for Agentforce and Data Cloud is approaching $3.9 billion, with Agentforce individually contributing approximately $1.5 billion in ARR. These AI-driven revenue figures are precisely the metrics that capture Wall Street’s interest.

Wall Street Weighs In

The analyst community has largely embraced the developments. Wolfe Research elevated its rating to “strong buy.” Truist Securities increased its price target to $300, while JPMorgan adjusted its objective to $265, matched by Mizuho. BMO Capital Markets lifted its target from $230 to $260 alongside an “outperform” designation. Both Evercore and Citizens JMP maintained their outperform recommendations.

However, not all analysts share the enthusiasm. UBS, Citi, Morgan Stanley, and Wells Fargo maintained neutral-equivalent ratings. Wells Fargo did raise its price target from $205 to $230 while retaining an “equal weight” stance. HC Wainwright took a contrarian position with a downgrade to “negative” issued in June. Bank of America continues its “underperform” rating with a $160 price objective. The consensus rating stands at “Moderate Buy” with an average price target of $261.15.

Some cautious analysts have noted that Anthropic could potentially dominate the AI orchestration infrastructure, which might constrain Salesforce’s strategic flexibility over the long term, despite near-term advantages.

Major Institutional Movements

Institutional capital has been flowing into CRM shares. BlackRock established a fresh position valued at approximately $11.4 billion. J. Stern and Co. expanded its holdings by an extraordinary 24,000%, now controlling over 47 million shares worth roughly $12.6 billion. Bank of America Corp DE and Norges Bank also initiated new positions. Institutional ownership currently represents 80.43% of outstanding shares.

Company leadership upgraded fiscal 2027 revenue guidance to a range of $46.1 billion to $46.4 billion and established Q3 2027 EPS guidance between $3.42 and $3.44. The stock’s 50-day moving average stands at $181.24, while the 200-day moving average sits at $182.47, both considerably below current trading levels.

✨ Limited Time Offer